SG64993G - Slow-release pharmaceutical composition - Google Patents
Slow-release pharmaceutical compositionInfo
- Publication number
- SG64993G SG64993G SG64993A SG64993A SG64993G SG 64993 G SG64993 G SG 64993G SG 64993 A SG64993 A SG 64993A SG 64993 A SG64993 A SG 64993A SG 64993 G SG64993 G SG 64993G
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- slow
- tryptophan
- fumaric acid
- release pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21327785 | 1985-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG64993G true SG64993G (en) | 1993-08-06 |
Family
ID=16636441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG64993A SG64993G (en) | 1985-09-26 | 1993-05-18 | Slow-release pharmaceutical composition |
Country Status (15)
Country | Link |
---|---|
US (1) | US5188840A (no) |
EP (2) | EP0386801B1 (no) |
JP (1) | JPH0772142B2 (no) |
KR (1) | KR950010145B1 (no) |
AT (2) | ATE62408T1 (no) |
AU (1) | AU587281B2 (no) |
CA (1) | CA1282327C (no) |
DE (2) | DE3689983T2 (no) |
DK (2) | DK166478B1 (no) |
ES (1) | ES2001993A6 (no) |
FI (1) | FI86146C (no) |
HK (1) | HK65393A (no) |
IE (2) | IE66255B1 (no) |
NO (1) | NO175763C (no) |
SG (1) | SG64993G (no) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3437300A1 (de) * | 1984-10-11 | 1986-04-17 | Fritz 5882 Meinerzhagen Sträter | Konzepthalter zur anwendung an schreib-, zeichen-, bildschirmarbeitsplaetzen u.dgl. |
KR940000232B1 (ko) * | 1986-01-17 | 1994-01-12 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 제제의 안정화 방법 |
US5057317A (en) * | 1987-03-24 | 1991-10-15 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
CA1323833C (en) * | 1987-04-28 | 1993-11-02 | Yatindra M. Joshi | Pharmaceutical compositions in the form of beadlets and method |
SE509029C2 (sv) * | 1988-08-16 | 1998-11-30 | Ss Pharmaceutical Co | Långtidsverkande diklofenak-natriumpreparat |
IT1256022B (it) * | 1992-06-08 | 1995-11-20 | Preparazioni farmaceutiche stabili di nicorandil | |
IT1255522B (it) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
US6183778B1 (en) | 1993-09-21 | 2001-02-06 | Jagotec Ag | Pharmaceutical tablet capable of liberating one or more drugs at different release rates |
US5602180A (en) * | 1995-03-31 | 1997-02-11 | World Health Group | Method of administering EDTA complexes |
SG80553A1 (en) * | 1995-07-20 | 2001-05-22 | Tanabe Seiyaku Co | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
FR2742659B1 (fr) * | 1995-12-22 | 1998-03-13 | Pf Medicament | Procede de fabrication de minispheres matricielles a liberation prolongee |
JP2001518493A (ja) * | 1997-10-03 | 2001-10-16 | スミスクライン・ビーチャム・コーポレイション | 炭酸リチウムの放出制御性固体投与形 |
EP1077065B1 (en) * | 1998-05-15 | 2004-08-04 | Chugai Seiyaku Kabushiki Kaisha | Controlled release formulations |
EP1203590B1 (en) * | 1999-08-09 | 2007-07-04 | Dainippon Sumitomo Pharma Co., Ltd. | Solid preparations containing chitosan powder and process for producing the same |
DE60038536T2 (de) | 1999-09-30 | 2009-06-10 | Penwest Pharmaceuticals Co. | Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe |
DE10031043A1 (de) | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
JP2004537506A (ja) | 2001-03-01 | 2004-12-16 | ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド | 血液細胞欠乏症を治療するためのある種のステロイドの使用 |
US6720356B2 (en) * | 2001-04-20 | 2004-04-13 | Spencer Feldman | Magnesium di-potassium EDTA complex and method of administration |
US7838026B2 (en) | 2001-09-28 | 2010-11-23 | Mcneil-Ppc, Inc. | Burst-release polymer composition and dosage forms comprising the same |
US7122143B2 (en) | 2001-09-28 | 2006-10-17 | Mcneil-Ppc, Inc. | Methods for manufacturing dosage forms |
BR0212951A (pt) * | 2001-09-28 | 2004-10-26 | Mcneil Ppc Inc | Formas de dosagens compósitas |
US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
US6837696B2 (en) * | 2001-09-28 | 2005-01-04 | Mcneil-Ppc, Inc. | Apparatus for manufacturing dosage forms |
US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
US20040166159A1 (en) * | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
US7094427B2 (en) * | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
US20030224045A1 (en) * | 2002-05-29 | 2003-12-04 | Chien-Hsuan Han | Combination immediate release sustained release levodopa/carbidopa dosage forms |
US20090035260A1 (en) * | 2002-07-29 | 2009-02-05 | Therapicon Srl | Enhanced nasal composition of active peptide |
US7807197B2 (en) * | 2002-09-28 | 2010-10-05 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
US20040228918A1 (en) * | 2003-01-02 | 2004-11-18 | Chih-Ming Chen | Granule modulating hydrogel system |
ITMI20040235A1 (it) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
DE102004039196B4 (de) | 2004-08-12 | 2008-07-31 | Dr.Kamprad Kg | Neue Formulierung für L-Tryptophan |
EP2471536A1 (en) | 2004-09-29 | 2012-07-04 | Harbor BioSciences, Inc. | Steroid analogs and characterization and treatment methods |
US8673352B2 (en) * | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
WO2013153210A1 (en) | 2012-04-13 | 2013-10-17 | Nanoscape Ag | Sustained-release formulation |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
WO2015054302A1 (en) | 2013-10-07 | 2015-04-16 | Impax Laboratories, Inc. | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
CN117618376A (zh) * | 2023-12-11 | 2024-03-01 | 江苏诺和必拓新药研发有限公司 | 一种尼可地尔膜控缓释片及其制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES300432A1 (es) * | 1963-06-04 | 1964-11-16 | Abbott Lab | Procedimiento para producir una composición analgésica |
US3577491A (en) * | 1968-01-02 | 1971-05-04 | Miles Lab | Tableting |
US3849558A (en) * | 1969-06-03 | 1974-11-19 | Sumitomo Chemical Co | Pharmaceutical compositions having controlled gastro-intestinal absorption |
US3608063A (en) * | 1969-08-15 | 1971-09-21 | Gilbert S Banker | Molecular drug entrapment process and compositions |
BE759520A (fr) * | 1969-11-28 | 1971-04-30 | Aspro Nicholas Ltd | Compositions d'aspirine |
US3903255A (en) * | 1971-05-17 | 1975-09-02 | Rohm & Haas | Effervescent potassium chloride tablet |
JPS5115094B2 (no) * | 1972-11-01 | 1976-05-14 | ||
US3993999A (en) * | 1975-05-16 | 1976-11-23 | Texas Instruments Incorporated | Amplitude modulation scanning antenna system |
US4021546A (en) * | 1976-03-08 | 1977-05-03 | Interx Research Corporation | Pro-drug forms of digoxin and method of preparing and using same |
DE2656227C2 (de) * | 1976-12-11 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
GB1576376A (en) * | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
US4180559A (en) * | 1978-01-05 | 1979-12-25 | Richardson-Merrell Inc. | Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions |
DE2841170A1 (de) * | 1978-09-21 | 1980-04-03 | Pharmazeutische Praeparate Apo | Hypnotikum |
US4342764A (en) * | 1979-05-29 | 1982-08-03 | Ciba-Geigy Corporation | Guanidine compounds, pharmaceutical compositions and use |
US4406896A (en) * | 1979-12-20 | 1983-09-27 | Merck & Co., Inc. | Adjuvants for rectal delivery of drug substances |
DE3011327A1 (de) * | 1980-03-24 | 1981-10-01 | Basf Ag, 6700 Ludwigshafen | 1-aroyl-2-phenylamino-2-imidazoline, ihre herstellung und verwendung |
ZA823333B (no) * | 1981-04-24 | 1983-11-14 | ||
IT1198386B (it) * | 1982-07-06 | 1988-12-21 | Lepetit Spa | Un prodotto a rilascio protratto contenente il suloctidile |
US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
US4503031A (en) * | 1982-12-17 | 1985-03-05 | Glassman Jacob A | Super-fast-starting-sustained release tablet |
HU191542B (en) * | 1983-04-08 | 1987-03-30 | Boehringer Ingelheim Ltd | Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance |
PH18946A (en) * | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
DE3315797A1 (de) * | 1983-04-30 | 1984-10-31 | Beiersdorf Ag, 2000 Hamburg | Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
US4530920A (en) * | 1983-11-07 | 1985-07-23 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist |
JPH0653658B2 (ja) * | 1984-12-17 | 1994-07-20 | 中外製薬株式会社 | 安定な錠剤の製造法 |
FR2588559B1 (fr) * | 1985-10-11 | 1988-03-11 | Bp Chimie Sa | Procede de polymerisation ou de copolymerisation d'alpha-olefines en presence d'un systeme catalytique ziegler-natta ameliore |
-
1986
- 1986-09-15 US US06/906,959 patent/US5188840A/en not_active Expired - Lifetime
- 1986-09-16 AU AU62730/86A patent/AU587281B2/en not_active Expired
- 1986-09-16 IE IE940953A patent/IE66255B1/en not_active IP Right Cessation
- 1986-09-16 IE IE246886A patent/IE81099B1/en not_active IP Right Cessation
- 1986-09-24 NO NO863796A patent/NO175763C/no not_active IP Right Cessation
- 1986-09-24 DK DK455286A patent/DK166478B1/da not_active IP Right Cessation
- 1986-09-25 AT AT86113193T patent/ATE62408T1/de not_active IP Right Cessation
- 1986-09-25 JP JP61226468A patent/JPH0772142B2/ja not_active Expired - Fee Related
- 1986-09-25 EP EP90107877A patent/EP0386801B1/en not_active Expired - Lifetime
- 1986-09-25 AT AT90107877T patent/ATE108647T1/de not_active IP Right Cessation
- 1986-09-25 CA CA000519060A patent/CA1282327C/en not_active Expired - Fee Related
- 1986-09-25 ES ES8602189A patent/ES2001993A6/es not_active Expired
- 1986-09-25 DE DE3689983T patent/DE3689983T2/de not_active Expired - Lifetime
- 1986-09-25 EP EP86113193A patent/EP0218148B1/en not_active Expired - Lifetime
- 1986-09-25 DE DE8686113193T patent/DE3678661D1/de not_active Expired - Lifetime
- 1986-09-26 FI FI863889A patent/FI86146C/fi not_active IP Right Cessation
- 1986-09-26 KR KR1019860008085A patent/KR950010145B1/ko not_active IP Right Cessation
-
1992
- 1992-08-31 DK DK108192A patent/DK170110B1/da not_active IP Right Cessation
-
1993
- 1993-05-18 SG SG64993A patent/SG64993G/en unknown
- 1993-07-08 HK HK653/93A patent/HK65393A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU587281B2 (en) | Slow-release pharmaceutical agent | |
FI881409A0 (fi) | Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle | |
HU892559D0 (en) | Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient | |
ATE158504T1 (de) | Brausemischungen enthaltend ibuprofen und verfahren | |
RU93036959A (ru) | Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства | |
EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
CA2380757A1 (en) | Pharmaceutical agent comprising a benzamide derivative as active ingredient | |
ES2174734A1 (es) | Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones. | |
GEP20053581B (en) | Pharmaceutical Composition and Method for Preparation Thereof | |
MY102368A (en) | Solid sustained-release composition | |
WO2001010415B1 (en) | A binder for pharmaceutical compositions |